跳至主要内容
临床试验/NCT05120531
NCT05120531已完成不适用

Finding the Contribution of the Autonomic Nervous System During Perioperative Events in Children With Down Syndrome

Children's Hospital Medical Center, Cincinnati1 个研究点 分布在 1 个国家目标入组 195 人开始时间: 2022年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
195
试验地点
1
主要终点
Ambulatory feasibility of VU-AMS monitor on patients without Down Syndrome

研究概览

简要总结

Children with Down syndrome (DS) often experience dangerously low heart rates on induction of anesthesia for routine procedures and this occurs at 10 times the rate of non-DS patients. Given that the cardiac output of children is heart rate dependent, bradycardia is especially perilous in this population.

Historically, individuals with DS were not expected to survive beyond childhood; consequently, correction of congenital anomalies, e.g. cardiac defects, was not frequently offered. Fortunately, today individuals with DS live into adulthood and surgical correction of anomalies is universally offered. Thus, increasing numbers of children with DS are exposed to anesthesia and at risk for this hemodynamic catastrophe. It is medically unacceptable and an autonomic nervous system mechanism will be sought.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
1 Month 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients who are overtly healthy as determined by medical evaluation including lack of diagnosis of Down Syndrome and children with Down Syndrome

排除标准

  • Contraindication to adhesive placement, eg, epidermolysis bullosa
  • Patient or parent refusal
  • Heart rate altering therapy such as beta blockers
  • During the study period, participants will abstain from ingesting caffeine- or xanthine-containing products (eg, coffee, tea, cola drinks, and chocolate) for [6 hours] before the start of the anesthetic.
  • Participants will be assumed not to be using tobacco or alcohol during the study period due to their young age.

结局指标

主要结局

Ambulatory feasibility of VU-AMS monitor on patients without Down Syndrome

时间窗: Immediately upon entry into Same Day Surgery patient room

Subjects will be observed for monitor use coming to the hospital for surgery. The two outcomes will be binary: wearing the device or not. We anticipate that 50% of subjects will be wearing the VU-AMS monitor on entry to the hospital on the day of surgery.

Operating room feasibility of VU-AMS monitor on patients with Down Syndrome

时间窗: Immediately prior to mask induction with sevoflurane

Subjects will be observed for monitor use throughout surgery. We anticipate that 80% of subjects will wear the VU-AMS in the operating room

Autonomic data including pre-ejection period and respiratory sinus arrhythmia among patients with Down Syndrome

时间窗: Beginning at time of bradycardia and continuing for the next 300 seconds.

Among subjects who become bradycardic with induction of anesthesia, we expect that the pre-ejection period will increase by 20%

Ambulatory feasibility of VU-AMS monitor on patients with Down Syndrome

时间窗: Immediately upon entry into Same Day Surgery patient room

Subjects will be observed for monitor use coming to the hospital for surgery. The two outcomes will be binary: wearing the device or not. We anticipate that 50% of subjects will be wearing the VU-AMS monitor on entry to the hospital on the day of surgery.

Operating room feasibility of VU-AMS monitor on patients without Down Syndrome

时间窗: Immediately prior to mask induction with sevoflurane

Subjects will be observed for monitor use throughout surgery. We anticipate that 80% of subjects will wear the VU-AMS in the operating room

Autonomic data including pre-ejection period and respiratory sinus arrhythmia among patients without Down Syndrome

时间窗: Beginning at time of bradycardia and continuing for the next 300 seconds.

Among subjects who become bradycardic with induction of anesthesia, we expect that the pre-ejection period will increase by 20%

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验